SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005713
Filing Date
2020-05-07
Accepted
2020-05-07 16:15:00
Documents
99
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lci-20200331x10q.htm 10-Q 2525218
2 EX-31.1 lci-20200331ex311cc4d26.htm EX-31.1 11198
3 EX-31.2 lci-20200331ex312b58d05.htm EX-31.2 11199
4 EX-32 lci-20200331xex32.htm EX-32 8546
  Complete submission text file 0001558370-20-005713.txt   11626578

Data Files

Seq Description Document Type Size
5 EX-101.INS lci-20200331.xml EX-101.INS 2994373
6 EX-101.SCH lci-20200331.xsd EX-101.SCH 66421
7 EX-101.CAL lci-20200331_cal.xml EX-101.CAL 88116
8 EX-101.DEF lci-20200331_def.xml EX-101.DEF 267771
9 EX-101.LAB lci-20200331_lab.xml EX-101.LAB 674107
10 EX-101.PRE lci-20200331_pre.xml EX-101.PRE 533000
Mailing Address 9000 STATE ROAD 9000 STATE ROAD PHLADELPHIA PA 19136
Business Address 9000 STATE RD PHILADELPHIA PA 19136 2153339000
LANNETT CO INC (Filer) CIK: 0000057725 (see all company filings)

IRS No.: 230787699 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31298 | Film No.: 20856552
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences